These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 30728149

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free Urine.
    Fredsøe J, Rasmussen AKI, Thomsen AR, Mouritzen P, Høyer S, Borre M, Ørntoft TF, Sørensen KD.
    Eur Urol Focus; 2018 Dec; 4(6):825-833. PubMed ID: 28753866
    [Abstract] [Full Text] [Related]

  • 3. Danish Prostate Cancer Consortium Study 1 (DPCC-1) protocol: Multicentre prospective validation of the urine-based three-microRNA biomarker model uCaP.
    Fredsøe J, Glud E, Boesen L, Løgager V, Poulsen MH, Pedersen BG, Borre M, Sørensen KD.
    BMJ Open; 2023 Nov 08; 13(11):e077020. PubMed ID: 37940151
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Profiling of Circulating microRNAs in Prostate Cancer Reveals Diagnostic Biomarker Potential.
    Fredsøe J, Rasmussen AKI, Mouritzen P, Bjerre MT, Østergren P, Fode M, Borre M, Sørensen KD.
    Diagnostics (Basel); 2020 Mar 28; 10(4):. PubMed ID: 32231021
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.
    Ghorbanmehr N, Gharbi S, Korsching E, Tavallaei M, Einollahi B, Mowla SJ.
    Prostate; 2019 Jan 28; 79(1):88-95. PubMed ID: 30194772
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer.
    Guzel E, Karatas OF, Semercioz A, Ekici S, Aykan S, Yentur S, Creighton CJ, Ittmann M, Ozen M.
    Int J Cancer; 2015 Feb 15; 136(4):875-9. PubMed ID: 24976077
    [Abstract] [Full Text] [Related]

  • 11. Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy Outcome.
    Juracek J, Madrzyk M, Trachtova K, Ruckova M, Bohosova J, Barth DA, Pichler M, Stanik M, Slaby O.
    Cancer Genomics Proteomics; 2023 Feb 15; 20(3):308-316. PubMed ID: 37093688
    [Abstract] [Full Text] [Related]

  • 12. A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy.
    McKiernan J, Donovan MJ, O'Neill V, Bentink S, Noerholm M, Belzer S, Skog J, Kattan MW, Partin A, Andriole G, Brown G, Wei JT, Thompson IM, Carroll P.
    JAMA Oncol; 2016 Jul 01; 2(7):882-9. PubMed ID: 27032035
    [Abstract] [Full Text] [Related]

  • 13. Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer.
    Kachakova D, Mitkova A, Popov E, Popov I, Vlahova A, Dikov T, Christova S, Mitev V, Slavov C, Kaneva R.
    DNA Cell Biol; 2015 Mar 01; 34(3):189-200. PubMed ID: 25521481
    [Abstract] [Full Text] [Related]

  • 14. Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis.
    Barceló M, Castells M, Bassas L, Vigués F, Larriba S.
    Sci Rep; 2019 Sep 24; 9(1):13772. PubMed ID: 31551516
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.
    Tomlins SA, Day JR, Lonigro RJ, Hovelson DH, Siddiqui J, Kunju LP, Dunn RL, Meyer S, Hodge P, Groskopf J, Wei JT, Chinnaiyan AM.
    Eur Urol; 2016 Jul 24; 70(1):45-53. PubMed ID: 25985884
    [Abstract] [Full Text] [Related]

  • 19. Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up.
    Johnson H, Guo J, Zhang X, Zhang H, Simoulis A, Wu AHB, Xia T, Li F, Tan W, Johnson A, Dizeyi N, Abrahamsson PA, Kenner L, Feng X, Zou C, Xiao K, Persson JL, Chen L.
    BMC Med; 2020 Dec 01; 18(1):376. PubMed ID: 33256740
    [Abstract] [Full Text] [Related]

  • 20. Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling.
    Kristensen H, Thomsen AR, Haldrup C, Dyrskjøt L, Høyer S, Borre M, Mouritzen P, Ørntoft TF, Sørensen KD.
    Oncotarget; 2016 May 24; 7(21):30760-71. PubMed ID: 27120795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.